Institutional & Family Asset Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-13
| Closed | -$131 | – | 734 |
|
2022
Q4 | $131 | Buy |
13
+8
| +160% | +$81 | ﹤0.01% | 703 |
|
2022
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 724 |
|
2022
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 739 |
|
2022
Q1 | $0 | Buy |
+5
| New | – | ﹤0.01% | 792 |
|
2021
Q4 | – | Sell |
-5
| Closed | – | – | 841 |
|
2021
Q3 | $0 | Sell |
5
-4
| -44% | – | ﹤0.01% | 926 |
|
2021
Q2 | $1K | Hold |
9
| – | – | ﹤0.01% | 884 |
|
2021
Q1 | $1K | Sell |
9
-5
| -36% | -$556 | ﹤0.01% | 860 |
|
2020
Q4 | $1K | Buy |
+14
| New | +$1K | ﹤0.01% | 831 |
|